Intro

This chapter explores the groundbreaking launch of CL1, a biological computer that merges human brain cells with silicon technology. It emphasizes the potential benefits for personalized medicine while addressing critical ethical issues and the necessity for clear legal frameworks in the evolving landscape of AI.